Health
Cosmetic Plant Expects 10% Growth This Year, Slight Growth In 2015
Romanian cosmetics producer Cosmetic Plant, based in Cluj-Napoca, estimates a slight growth in turnover next year, after an expected 10% growth this year, to EUR1.7 million.
Labormed Raises Share Capital By EUR55M, Alvogen Lux Holdings Becomes Shareholder
Romanian generic drug producer Labormed Pharma will raise its share capital by EUR55 million by converting into shares part of a EUR85.28 million receivable it owes Alvogen Lux Holdings S.a....
Sarantis Turnover In Romania Up 8.45% In January-September, To EUR28.4M
Greek group Sarantis, owner of cosmetics producer Elmiplant, posted a 8.45% growth in turnover in Romania in January-September, to EUR28.46 million, and a 5.26% in its profit before interest...
Regina Maria To Invest EUR4M In Expansion Next Year, Targets 20% Growth In Turnover
Private medical service provider Regina Maria will invest more than EUR4 million in network expansion in 2015 and estimates a 20% growth in turnover, a company official said Monday.
Weight Loss Surgery Hospital Ponderas Relocates To Office Building
Weight loss surgery hospital Ponderas will move from the Dristor area of Bucharest to Art Business Center office building on Nicolae Caramfil Street in the north of the city early next year,...
Dan Ivan, Actavis: We Thoroughly Changed Our Business Model
Retail sales (via pharmacies) are now at more than 60% of the total at the moment, because of a decision made to change the business model at the end of 2011, says Dan Ivan, general manager...
Antibiotice Sales Revenue Flat In First 9 Months, At RON217M
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Friday said its sales revenues were flat on the year at 217.2 million lei (EUR48.8 million) in January-September 2014.
Biofarm 9-Month Sales Up 4.6% On Year, To RON88.5M
Romanian drugmaker Biofarm (BIO.RO) Friday said its sales rose 4.6% to 89.48 million lei (EUR20.2 million) in the first nine months of 2014, from RON85.57 million in the same period in 2013.
Ropharma Profit Up 21% To RON5.3M In January-September
Pharmaceutical company Ropharma Brasov (RPH.RO) reported sales worth 306 million lei (EUR69.2 million) in the first nine months of the year, similar with the year-earlier period, while its p...